Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes-Reference-Cited by-同舟云学术

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes

Published:2021-08-26 Issue:9 Volume:385 Page:815-825
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Barry Peter J.¹,Mall Marcus A.¹,Álvarez Antonio¹,Colombo Carla¹,de Winter-de Groot Karin M.¹,Fajac Isabelle¹,McBennett Kimberly A.¹,McKone Edward F.¹,Ramsey Bonnie W.¹,Sutharsan Sivagurunathan¹,Taylor-Cousar Jennifer L.¹,Tullis Elizabeth¹,Ahluwalia Neil¹,Jun Lucy S.¹,Moskowitz Samuel M.¹,Prieto-Centurion Valentin¹,Tian Simon¹,Waltz David¹,Xuan Fengjuan¹,Zhang Yaohua¹,Rowe Steven M.¹,Polineni Deepika¹

Affiliation:

1. From Manchester University NHS Foundation Trust, Manchester, United Kingdom (P.J.B.); Charité–Universitätsmedizin Berlin, the Berlin Institute of Health, and the German Center for Lung Research, Berlin (M.A.M.), and the Division of Cystic Fibrosis, Department of Pulmonary Medicine, University Medicine Essen–Ruhrlandklinik, University of Duisburg–Essen, Essen (S.S.) — all in Germany; Vall d’Hebron Barcelona Hospital Campus, Barcelona (A.A.); Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and...

Funder

Vertex Pharmaceuticals

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2100665

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnancy and fertility in people with cystic fibrosis following lung transplantation;Current Opinion in Pulmonary Medicine;2024-08-27

2. The forgotten pandemic: how understanding cholera illuminated mechanisms of chloride channels in multiple diseases;Journal of Clinical Investigation;2024-08-15

3. DNA-PKcs Inhibition Improves Sequential Gene Insertion of the Full-LengthCFTRcDNA in Airway Stem Cells;2024-08-12

4. Cystic fibrosis;Nature Reviews Disease Primers;2024-08-08

5. Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis;APMIS;2024-08-02